NO20001847L - New use of compounds for anti-itch activity - Google Patents

New use of compounds for anti-itch activity

Info

Publication number: NO20001847L
Authority: NO; Norway
Prior art keywords: compounds; new use; itch activity; itch; activity
Prior art date: 1997-10-17

Application number

NO20001847A

Other languages

Norwegian (no)

Other versions

NO20001847D0 (en

Inventor

Don Edgar Griswold

Iv Siegfried Benja Christensen

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-17

Filing date

2000-04-10

Publication date

2000-04-10

2000-04-10 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2000-04-10 Publication of NO20001847L publication Critical patent/NO20001847L/en

2000-04-10 Publication of NO20001847D0 publication Critical patent/NO20001847D0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20001847A 1997-10-17 2000-04-10 New use of compounds for anti-itch activity NO20001847D0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US6374697P	1997-10-17	1997-10-17
PCT/US1998/021886 WO1999020280A1 (en)	1997-10-17	1998-10-16	Novel use of compounds for anti-pruritic activity

Publications (2)

Publication Number	Publication Date
NO20001847L true NO20001847L (en)	2000-04-10
NO20001847D0 NO20001847D0 (en)	2000-04-10

Family

ID=22051225

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20001847A NO20001847D0 (en)	1997-10-17	2000-04-10	New use of compounds for anti-itch activity

Country Status (18)

Country	Link
EP (1)	EP1030666A4 (en)
JP (1)	JP2001520196A (en)
KR (1)	KR20010031149A (en)
CN (1)	CN1306426A (en)
AR (1)	AR015966A1 (en)
AU (1)	AU740875B2 (en)
BR (1)	BR9814080A (en)
CA (1)	CA2306985A1 (en)
CO (1)	CO4810374A1 (en)
CZ (1)	CZ20001376A3 (en)
HU (1)	HUP0003792A3 (en)
IL (1)	IL135581A0 (en)
NO (1)	NO20001847D0 (en)
NZ (1)	NZ503551A (en)
PL (1)	PL341062A1 (en)
TR (1)	TR200001040T2 (en)
WO (1)	WO1999020280A1 (en)
ZA (1)	ZA989450B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL156412A0 (en)	2001-01-31	2004-01-04	Pfizer Prod Inc	Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
KR20030074761A (en)	2001-01-31	2003-09-19	화이자 프로덕츠 인크.	Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
US7250518B2 (en)	2001-01-31	2007-07-31	Pfizer Inc.	Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
CA2436544A1 (en)	2001-01-31	2002-08-08	Pfizer Products Inc.	Ether derivatives useful as inhibitors of pde4 isozymes
US20030175314A1 (en) *	2001-11-19	2003-09-18	Didriksen Erik Johannes	Pharmaceutical composition for dermal application
EP1647274A4 (en) *	2003-07-17	2008-12-10	Ono Pharmaceutical Co	Remedy for pruritus comprising piperidine derivative as the active ingredient
WO2005053672A1 (en) *	2003-12-04	2005-06-16	Santen Pharmaceutical Co., Ltd.	Remedy for pruritus comprising cilomilast or salt thereof as the active ingredient
JP2005187458A (en) *	2003-12-04	2005-07-14	Santen Pharmaceut Co Ltd	Itchiness-treating agent consisting of cilomilast or its salt as active ingredient
CN101103030B (en) *	2004-02-14	2010-10-13	史密丝克莱恩比彻姆公司	Medicaments with HM74A receptor activity
JP2008137892A (en) *	2005-03-04	2008-06-19	Eisai Co Ltd	Antipruritic agent
EA200800564A1 (en)	2005-08-10	2008-08-29	Смитклайн Бичам Корпорейшн	DERIVATIVES OF XANTHINE AS SELECTIVE AGONISTS NM74A
TWI404709B (en) *	2006-02-21	2013-08-11	Eisai R&D Man Co Ltd	4-(3-benzamidophenyl) -6,7-dimethoxy-2-methylamine quinazoline derivatives
CA2637573C (en) *	2006-02-21	2013-07-02	Eisai R&D Management Co., Ltd.	4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives
AU2008215411B2 (en)	2007-02-16	2012-11-22	Eisai R & D Management Co., Ltd.	Crystal, amorphous form and salt of methyl N-[3-(6,7-dimethoxy- 2-methylaminoquinazolin-4-yl)phenyl]terephthalamic acid
CN101687820B (en)	2007-08-17	2012-07-25	卫材R&D管理有限公司	Method for producing quinazoline derivative
TWI414296B (en)	2007-08-17	2013-11-11	Eisai R&D Man Co Ltd	Innovative agents
JP5985475B2 (en) *	2011-06-28	2016-09-06	田辺三菱製薬株式会社	New pharmaceutical composition
SG11201705889VA (en)	2015-01-30	2017-08-30	Shanton Pharma Co Ltd	Prevention or Treatment of Uratic or Gouty Diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2098846A1 (en) *	1990-12-21	1992-06-22	David G. Smith	Xanthine derivatives
DE59708265D1 (en) *	1996-03-26	2002-10-24	Altana Pharma Ag	NEW PHENANTHRIDINE SUBSTITUTED IN 6-POSITION
ATE228131T1 (en) *	1996-05-15	2002-12-15	Altana Pharma Ag	IMIDAZOPYRIDINES
JP2001514640A (en) *	1997-03-07	2001-09-11	ビイクグルデンロンベルクヒエーミツシエフアブリークゲゼルシヤフトミツトベシユレンクテルハフツング	New tetrazole
CN1269722A (en) *	1997-03-18	2000-10-11	Basf公司	Method and composition for modulating responsiveness to corticosteroids
PT988302E (en) *	1997-06-03	2003-07-31	Altana Pharma Ag	BENZONAFTIRIDINES

1998
- 1998-10-15 AR ARP980105131A patent/AR015966A1/en not_active Application Discontinuation
- 1998-10-16 KR KR1020007004053A patent/KR20010031149A/en not_active Application Discontinuation
- 1998-10-16 CZ CZ20001376A patent/CZ20001376A3/en unknown
- 1998-10-16 TR TR2000/01040T patent/TR200001040T2/en unknown
- 1998-10-16 EP EP98953608A patent/EP1030666A4/en not_active Withdrawn
- 1998-10-16 ZA ZA989450A patent/ZA989450B/en unknown
- 1998-10-16 JP JP2000516677A patent/JP2001520196A/en not_active Withdrawn
- 1998-10-16 WO PCT/US1998/021886 patent/WO1999020280A1/en not_active Application Discontinuation
- 1998-10-16 NZ NZ503551A patent/NZ503551A/en unknown
- 1998-10-16 IL IL13558198A patent/IL135581A0/en unknown
- 1998-10-16 CA CA002306985A patent/CA2306985A1/en not_active Abandoned
- 1998-10-16 AU AU10938/99A patent/AU740875B2/en not_active Ceased
- 1998-10-16 HU HU0003792A patent/HUP0003792A3/en unknown
- 1998-10-16 PL PL98341062A patent/PL341062A1/en unknown
- 1998-10-16 CN CN98810066A patent/CN1306426A/en active Pending
- 1998-10-16 CO CO98060225A patent/CO4810374A1/en unknown
- 1998-10-16 BR BR9814080-9A patent/BR9814080A/en not_active IP Right Cessation
2000
- 2000-04-10 NO NO20001847A patent/NO20001847D0/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1030666A4 (en)	2002-10-16
CA2306985A1 (en)	1999-04-29
CN1306426A (en)	2001-08-01
CZ20001376A3 (en)	2002-06-12
EP1030666A1 (en)	2000-08-30
NO20001847D0 (en)	2000-04-10
HUP0003792A3 (en)	2001-12-28
CO4810374A1 (en)	1999-06-30
NZ503551A (en)	2002-05-31
JP2001520196A (en)	2001-10-30
AU740875B2 (en)	2001-11-15
AU1093899A (en)	1999-05-10
AR015966A1 (en)	2001-05-30
HUP0003792A2 (en)	2001-10-28
KR20010031149A (en)	2001-04-16
TR200001040T2 (en)	2001-01-22
ZA989450B (en)	1999-04-19
WO1999020280A1 (en)	1999-04-29
PL341062A1 (en)	2001-03-26
BR9814080A (en)	2000-09-26
IL135581A0 (en)	2001-05-20

Publication	Publication Date	Title
CY2012029I2 (en)	2015-08-05	NEW FORM OF 5-OMEPRAZOLE
EE200000044A (en)	2000-10-16	New compounds
ID24372A (en)	2000-07-13	COMPOUNDS OF 4-AMINO-TIAZOL-2-IL COMPOUNDS AS CDKERS
IS5338A (en)	2000-01-13	New Spiroasabicyclic Heterocyclic Compounds
FI972292A (en)	1998-12-01	Management of diabetes
ID24638A (en)	2000-07-27	COMPOUNDS OF ANTI ARYTHMIA BISPIDINA
NO20015855L (en)	2002-01-30	New use of compounds as antibacterial agents
NO20001847L (en)	2000-04-10	New use of compounds for anti-itch activity
NO993298D0 (en)	1999-07-02	New procedure
ID29966A (en)	2001-10-25	SULFONYLOKSAZOLAMINA-SULFONYLOKSAZOLAMINA AS ACTIVE COMPOUNDS OF THERAPY
ID24677A (en)	2000-07-27	COMBINATION OF FUNICIDAL ACTIVE COMPOUNDS
NO995796L (en)	1999-11-26	New procedure
ID24270A (en)	2000-07-13	REMOVAL OF KERATOTIC CONSTITIONS
NO996438D0 (en)	1999-12-23	New combination of asthma drugs
FI963532A0 (en)	1996-09-09	New use of quinoline-3-carboxamide compounds
FI963531A (en)	1996-09-09	New use of quinoline-3-carboxamide compounds
ID24694A (en)	2000-08-03	USAGE OF SUBSTANCE AS CATALYST FOR THE MAKING OF CAPROLAKTAM
ID24439A (en)	2000-07-20	USE OF TIAZOLIDINDION FOR HYPERGLICEMIA TREATMENT
ID19787A (en)	1998-07-30	COMPOUND 25-HYDROXY-16-ENA-26,27-BISHOMO-COLLECTION OF FERROL
ID24521A (en)	2000-07-20	USE OF TIAZOLIDINDION FOR HYPERGLICEMIA TREATMENT
NO963762D0 (en)	1996-09-09	New use of quinoline-3-carboxamide compounds
NO963764D0 (en)	1996-09-09	New use of quinoline-3-carboxamide compounds
SE9702747D0 (en)	1997-07-18	New compounds
SE9701220D0 (en)	1997-04-04	New compounds
SE9704837D0 (en)	1997-12-22	New compounds

Legal Events

Date	Code	Title	Description
2004-10-18	FC2A	Withdrawal, rejection or dismissal of laid open patent application